https://www.selleckchem.com/pr....oducts/avacopan-ccx1
Background and Purpose End-of-procedure substantial reperfusion [modified Treatment in Cerebral Ischemia (mTICI) 2b-3], the leading endpoint for thrombectomy studies, has several limitations including a ceiling effect, with recent achieved rates of ~90%. We aimed to identify a more optimal definition of angiographic success along two dimensions (1) the extent of tissue reperfusion, and (2) the speed of revascularization. Methods Core-lab adjudicated TICI scores for the first three passes of EmboTrap and the final all-procedures